Search research articles
Contact Us
Filters
Showing results (51-60 of 75) with videos related to
Page
of 8
Sort By:
The Oncologist
|
June 2, 2019
Characteristics of <i>BRAF</i><sup></sup> Mutant, Deficient Mismatch Repair/Proficient Mismatch Repair, Metastatic Colorectal Cancer: A Multicenter Series of 287 Patients
Christelle de la Fouchardière, Romain Cohen, David Malka, et al.
Journal for Immunotherapy of Cancer
|
February 19, 2020
Safety and efficacy of restarting immune checkpoint inhibitors after clinically significant immune-related adverse events in metastatic renal cell carcinoma
Sarah Abou Alaiwi, Wanling Xie, Amin H Nassar, et al.
World Journal of Urology
|
January 3, 2025
The effect of tumor downsizing on surgical complexity during nephrectomy after immune checkpoint inhibitors for metastatic renal cell carcinoma
Geraldine Pignot, Gaelle Margue, Pierre Bigot, et al.
European Journal of Cancer (Oxford, England : 1990)
|
February 21, 2024
Safety and efficacy of nivolumab in elderly patients with metastatic clear cell renal cell carcinoma: Analysis of the NIVOREN GETUG-AFU 26 study
Loïc Mourey, Larissa Tames Rainho, Cécile Dalban, et al.
Science Advances
|
November 8, 2023
Human virome profiling identified CMV as the major viral driver of a high accumulation of senescent CD8<sup>+</sup> T cells in patients with advanced NSCLC
Marie Naigeon, Matthieu Roulleaux Dugage, François-Xavier Danlos, et al.
NPJ Precision Oncology
|
July 18, 2024
Metastatic renal cell carcinoma with occult primary: a multicenter prospective cohort
Nicolas Jacquin, Ronan Flippot, Julien Masliah-Planchon, et al.
European Journal of Cancer (Oxford, England : 1990)
|
April 4, 2025
Activity of lenvatinib-based therapy in previously treated patients with metastatic renal cell carcinoma: A European multicenter study (LENVA-LAT)
Javier Gavira, Edouard Auclin, Macarena Rey-Cardenas, et al.
British Journal of Cancer
|
January 25, 2024
Exposure-response relationship of cabozantinib in patients with metastatic renal cell carcinoma treated in routine care
Benoit Blanchet, Alexandre Xu-Vuilard, Anne Jouinot, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
June 14, 2019
Safety and Efficacy of Nivolumab in Brain Metastases From Renal Cell Carcinoma: Results of the GETUG-AFU 26 NIVOREN Multicenter Phase II Study
Ronan Flippot, Cécile Dalban, Brigitte Laguerre, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
November 14, 2019
Results of a Multicenter Phase II Study of Atezolizumab and Bevacizumab for Patients With Metastatic Renal Cell Carcinoma With Variant Histology and/or Sarcomatoid Features
Bradley A McGregor, Rana R McKay, David A Braun, et al.
Page
of 8
Search research articles
Search
Showing results (51-60 of 75) with videos related to
Sort By:
Page
of 8
The Oncologist
|
June 2, 2019
Characteristics of <i>BRAF</i><sup></sup> Mutant, Deficient Mismatch Repair/Proficient Mismatch Repair, Metastatic Colorectal Cancer: A Multicenter Series of 287 Patients
Christelle de la Fouchardière, Romain Cohen, David Malka, et al.
Journal for Immunotherapy of Cancer
|
February 19, 2020
Safety and efficacy of restarting immune checkpoint inhibitors after clinically significant immune-related adverse events in metastatic renal cell carcinoma
Sarah Abou Alaiwi, Wanling Xie, Amin H Nassar, et al.
World Journal of Urology
|
January 3, 2025
The effect of tumor downsizing on surgical complexity during nephrectomy after immune checkpoint inhibitors for metastatic renal cell carcinoma
Geraldine Pignot, Gaelle Margue, Pierre Bigot, et al.
European Journal of Cancer (Oxford, England : 1990)
|
February 21, 2024
Safety and efficacy of nivolumab in elderly patients with metastatic clear cell renal cell carcinoma: Analysis of the NIVOREN GETUG-AFU 26 study
Loïc Mourey, Larissa Tames Rainho, Cécile Dalban, et al.
Science Advances
|
November 8, 2023
Human virome profiling identified CMV as the major viral driver of a high accumulation of senescent CD8<sup>+</sup> T cells in patients with advanced NSCLC
Marie Naigeon, Matthieu Roulleaux Dugage, François-Xavier Danlos, et al.
NPJ Precision Oncology
|
July 18, 2024
Metastatic renal cell carcinoma with occult primary: a multicenter prospective cohort
Nicolas Jacquin, Ronan Flippot, Julien Masliah-Planchon, et al.
European Journal of Cancer (Oxford, England : 1990)
|
April 4, 2025
Activity of lenvatinib-based therapy in previously treated patients with metastatic renal cell carcinoma: A European multicenter study (LENVA-LAT)
Javier Gavira, Edouard Auclin, Macarena Rey-Cardenas, et al.
British Journal of Cancer
|
January 25, 2024
Exposure-response relationship of cabozantinib in patients with metastatic renal cell carcinoma treated in routine care
Benoit Blanchet, Alexandre Xu-Vuilard, Anne Jouinot, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
June 14, 2019
Safety and Efficacy of Nivolumab in Brain Metastases From Renal Cell Carcinoma: Results of the GETUG-AFU 26 NIVOREN Multicenter Phase II Study
Ronan Flippot, Cécile Dalban, Brigitte Laguerre, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
November 14, 2019
Results of a Multicenter Phase II Study of Atezolizumab and Bevacizumab for Patients With Metastatic Renal Cell Carcinoma With Variant Histology and/or Sarcomatoid Features
Bradley A McGregor, Rana R McKay, David A Braun, et al.
Page
of 8